Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry

References

• Ames B. N., McCann J., Yamaski E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutation Research 1975; 31: 347–364
   PubMed Web of Science ®Google Scholar
• Arnoux P., Morrison R. Drug analysis in biological samples. A survey on validation approaches in chromatography. Xenobiotica 1992, in press
   PubMed Web of Science ®Google Scholar
• Beresford A. P., Caswell K., Chambers R., Kirk I. P. Advantages of a chiral HPLC as a preparative step for chiral analysis in biological samples: assays for GR92549 and GR50360 enantiomers using protein stationary phases. Xenobiotica 1992, in press
   PubMedGoogle Scholar
• Caprioli R. M. Continuous Flow Fast Atom Bombardment Mass Spectrometry, R. M. Caprioli. John Wiley & Sons Ltd., Chichester 1990; 63–92
   Google Scholar
• Case D. E. The State of the Art: a commentary on the current practice of metabolism and pharmacokinetic studies in the pharmaceutical industry. Xenobiotica 1981; 11: 803–814
   PubMed Web of Science ®Google Scholar
• Collins J. M., Grieshaber C. K., Chabner B. A. Pharmacology guided Phase I clinical trials based upon preclinical drug development. Journal of the National Cancer Institute 1990; 82: 1321
   PubMed Web of Science ®Google Scholar
• Commission of the European Communities. Guidelines on the Quality, Safety and Efficacy of Medicinal Products for Human Use. 1989a
   Google Scholar
• Commission of the European, Communities. Notice to Applicants for Marketing Authorities for Proprietary Medicinal Products for Human Use in the Member States of the European Community. 1989b
   Google Scholar
• Commission of the European Communities. CPMP Working Party on Safety of Medicinal Products: Note for Guidance. 1990a, Recommendations for the Development of Non-clincal Testing Strategies (Draft No. 7)
   Google Scholar
• Commission of the European Communities. CPMP Working Party in Efficacy of Medicinal Products: Note for Guidance. 1990b, Investigation of Bioavailability and Bioequivalence (Draft)
   Google Scholar
• Cunningham V. J., Pike V. W., Bailey D., Freemantle C. A. J., Page B. C., Jones A. K. P., Kensett M. J., Bateman D., Luthra S. K., Jones T. A method for studying pharmacokinetics in man at picomolar drug concentrations. British Journal of Clinical Pharmacology 1991; 32: 167–172
   PubMed Web of Science ®Google Scholar
• Davies D. S. An introduction to metabolic and kinetic aspects of toxicological studies. Xenobiotic 1988; 18(Suppl. 1)3–7
   PubMedGoogle Scholar
• Doyle E., Huber R., Picot V. S. Direct injection/HPLC methods for the analysis of drugs in biological samples and their application to pharmacokinetic studies in the rat. Xenobiotica 1992; 22: 765–774
   PubMed Web of Science ®Google Scholar
• DHSS. MAL-4: Notes on Application for Clinical Trial Certificates (Medicines for Human Use). 1977
   Google Scholar
• Gilbert P. J., Hartley T. E., Troke J. A., Turcan R. G., Vose C. W., Watson K. W. The application of 19F-NMR spectroscopy to the identification of dog urinary metabolites of imirestat a spirohydantoin aldose reductase inhibitor. Xenobiotica 1992; 22: 775–788
   PubMed Web of Science ®Google Scholar
• Heim M., Meyer U. A. Predicting debrisoquine phenotype. Lancet 1991; 337: 363
   PubMed Web of Science ®Google Scholar
• Hughes K. M., Lang J. C. T., Lazare R., Gordon D., Stanton S. L., Malone-Lee J., Geraint M. The measurement of oxybutynin and its N-desethyl metabolite in plasma and its application to pharmacokinetic studies in young volunteers and elderly and frail elderly patient volunteers. Xenobiotica 1992; 22: 859–870
   PubMed Web of Science ®Google Scholar
• Humphrey M., Smith D. A. The role of metabolism and pharmacokinetic studies in the discovery of new drugs and their development—present and future perspectives. Xenobiotica 1992; 22: 743–756
   PubMed Web of Science ®Google Scholar
• Hutt A. J. Progress in Drug Metabolism, G. G. Gibson. Taylor and Francis, London 1990; Vol. 12: 147–204
   Google Scholar
• Ings R. M. J., Lucas C., Lievre E., Areliet C., Clavel M., Levyraz S., Minaidis D., Lokiec F., Turpin F. The pharmacokinetics and pharmacodynamics of a new vinca alkaloid, S 12363, using data from a Phase I tolerance study in man. Xenobiotica 1992; 22: 871–880
   PubMed Web of Science ®Google Scholar
• Lavrijsen K., Van Houdt J., Van Dyck D., Hendrickx J., Bockx M., Hurkmans R., Meuldermans W., Jeune Le, Lauwers L. W., Heykants J. Compariative metabolism of flunarizine in rats, dogs and man. An in vitro study with subcellular liver fractions and isolated hepatocytes. Xenobiotica 1992; 22: 815–836
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Coon M. J., Estabrook R. W., Feyereisen R., Fujiikuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Loper V. C., Sato R., Waterman M. R., Waxman D. J. The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA and Cell Biology 1991; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Pidgen A. Statistical aspects of bioequivalance—a review. Xenobiotica 1992, in press
   PubMed Web of Science ®Google Scholar
• Preece N. E., Timbrell J. A. Progress in Drug Metabolism, G. G. Gibson. Taylor and Francis, London 1990; Vol. 12: 147–204
   Google Scholar
• Ryan D. E., Thomas P. E., Reik L. M., Levin W. Purification, characterisation and regulation of five rat hepatic microsmal cytochrome P-450 isoenzymes. Xenobiotica 1982; 12: 727–744
   PubMed Web of Science ®Google Scholar
• Shimada T., Iwasaka M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium, TA1535/pSK1002. Cancer Research 1989; 49: 3218–3228
   PubMed Web of Science ®Google Scholar
• Tomlinson P. W., Ramji J. V., Filer C. W. The disposition of the enantiomers of chromakalim in rat and cynmolgus monkey. Xenobiotica 1992, in press
   PubMed Web of Science ®Google Scholar
• Waterman M. R. ACTH-mediated induction of synthesis and activity of cytochrome P-450 and related enzymes in cultivated bovine adrenocortical cells. Xenobiotica 1982; 12: 773–786
   PubMed Web of Science ®Google Scholar
• Wiltshire H. R., Harris S. R., Prior K. J., Kozlowski U. M., Worth E. The metabolism of the calcium antagonist Ro 40–5967: a case history of the use of diode array (UV spectroscopy and thermospray mass spectrometry in the elucidation of a complex metabolic pathway. Xenobiotica 1992, in press
   Web of Science ®Google Scholar
• Wolf C. R., Moss J. E., Miles J. S., Gough A. C., Spurr N. K. Detection of debrisoquine phenotype. Lancet 1990; 336: 1452–1453
   PubMed Web of Science ®Google Scholar